EMA opens consultation on platform trial methodology; MHRA to recognize CE-marked devices indefinitely
The European Medicines Agency is launching a public consultation to gather feedback on the methodological aspects of confirmatory platform clinical trials.
The agency seeks input from researchers, sponsors and other stakeholders to help shape future guidance for these multi‑arm studies.
In the United Kingdom, the Medicines and Healthcare products Regulatory Agency announced it will continue to recognize CE‑marked medical devices without a set expiration date.
The decision aims to provide ongoing regulatory certainty for device manufacturers and healthcare providers.
This writeup was produced by pharmadog from original reporting by raps.
Original headline: “Euro Roundup: EMA seeks feedback on platform trials; MHRA to recognize CE-marked devices indefinitely”
read at raps ↗
comments(0)
5-min edit window · permanent after that